What is Hexoskin?
Founded in 2006 and headquartered in Quebec, Canada, Hexoskin is a pioneer in health technology, offering advanced solutions in non-invasive sensors, software, data science, and AI. The company serves a diverse clientele across security, defense, aerospace, first responders, pharmaceuticals, academia, and healthcare organizations. Hexoskin's expertise lies in translating complex biological data into actionable insights through its proprietary technology.
How much funding has Hexoskin raised?
Hexoskin has raised a total of $5.5M across 2 funding rounds:
Angel/Seed
$1.3M
Other Financing Round
$4.2M
Angel/Seed (2015): $1.3M with participation from Anges Québec
Other Financing Round (2024): $4.2M led by AQC Capital, BDC Capital Management, and Anges Québec
Key Investors in Hexoskin
Anges Québec
Anges Québec is a prominent network of angel investors in Canada, dedicated to supporting passionate entrepreneurs and innovative projects. They provide capital and strategic guidance to help businesses thrive.
AQC Capital
AQC Capital helps Quebec's most promising startup teams turn big ideas into global businesses, providing financial support and guidance from early stages to market success.
BDC Capital Management
BDC Capital Management is an investment advisory firm specializing in financial planning services, focusing on values-based investing to align clients' financial strategies with their personal beliefs.
What's next for Hexoskin?
The recent major strategic investment signals a new phase of growth and development for Hexoskin. This capital infusion is expected to accelerate the company's innovation in AI-driven health analytics and expand its reach into critical sectors such as defense and healthcare. Hexoskin's focus on non-invasive sensing technology positions it to capitalize on the growing demand for remote patient monitoring and advanced biometric data solutions, further solidifying its market leadership.
See full Hexoskin company page
